Broenshoej, Denmark

Ole Hvilsted Olsen

This inventor holds 43 USPTO granted patents and 23 published patent applications, plus 2 CIPO patents and 11 EPO patents, primarily in Coagulation Factors. Top assignees: Novo Nordisk A/s, Novo Nordisk Healthcare Ag, Sanquin Blood Supply Foundation. Active years: 1996-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ole Hvilsted Olsen. Retrieved from https://idiyas.com/inventor/ole-hvilsted-olsen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 43 

% Patents Active = 53.5

 

 

Average Co-Inventor Count = 4.5

ph-index = 16

Forward Citations = 593(Granted Patents)


Location History:

  • Br.o slashed.nsh.o slashed.j, DK (1996 - 2000)
  • Copenhagen, DK (2002)
  • Bronshoj, DK (1999 - 2008)
  • Brønshøj, DK (2001 - 2013)
  • Broenshoej, DK (1996 - 2021)

Company Filing History:


Years Active: 1996-2021

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Factor VIII Variants
Coagulation Factor VII
Antibodies
Haemophilia Treatment
Nucleic Acids
Protein Tyrosine Phosphatases
Modified Subtilisins
Pharmaceutical Formulation
Growth Hormone Compounds
Detergent Compositions
Human Kunitz-Type Protease Inhibitors
43 patents (USPTO):Explore Patents

Title: Ole Hvilsted Olsen: Innovating Across Industries

Introduction:

Throughout his illustrious career, Ole Hvilsted Olsen has emerged as an exceptional innovator, leaving a lasting impact on technology, engineering, and manufacturing. With his inventive mindset and problem-solving abilities, Olsen has spearheaded the development of novel solutions that have revolutionized various sectors. From his extraordinary number of patents to his contributions in esteemed companies like Novo Nordisk A/S and Novo Nordisk Healthcare AG, Olsen's journey exemplifies a relentless pursuit of innovation.

Latest Patents:

Olsen's innovative prowess is best showcased through his latest patents. One such breakthrough is the development of "Factor VIII variants having a decreased cellular uptake." This invention focuses on modified coagulation factors, particularly modified Factor VIII molecules with reduced cellular uptake. By significantly advancing the field of coagulation factors, Olsen's patent has the potential to enhance treatment options for individuals with bleeding disorders. Building on this achievement, Olsen has exemplified his commitment to pushing the boundaries of science and improving lives.

Career Highlights:

Over the course of his career, Olsen has achieved remarkable milestones. His journey has been marked by 42 patents, a testament to his unwavering dedication to innovation. Through his extensive knowledge and expertise, he has consistently sought to improve existing technologies and push the boundaries of what is possible. Olsen's contributions have significantly impacted the domains of technology, engineering, and manufacturing, leaving an indelible mark on each industry he has worked in.

Collaborations:

Collaboration has been a key aspect of Olsen's innovative journey. His collaborations with esteemed colleagues, such as Egon Persson and Sven Branner, have resulted in groundbreaking inventions and propelled advancements in various fields. By fostering an environment of open communication and shared knowledge, Olsen has successfully harnessed the power of collaboration to drive innovation. His ability to bring together diverse perspectives and expertise has been critical in solving complex problems and achieving extraordinary results.

Conclusion:

Ole Hvilsted Olsen's career stands as a testament to the power of innovation and creative problem-solving. His groundbreaking inventions, diverse career highlights, and collaborations highlight his ability to excel across industries. Whether revolutionizing coagulation factors or making significant contributions to technology, engineering, and manufacturing, Olsen's work showcases his unwavering commitment to pushing boundaries and making a lasting impact. As the world continues to evolve, innovators like Olsen will play a critical role in shaping the future of industries and ultimately improving the lives of countless individuals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…